| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 1.22e-06 | 265 | 60 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.52e-06 | 37 | 60 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.38e-04 | 739 | 60 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 3.84e-04 | 206 | 60 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | retromer complex binding | 3.93e-04 | 10 | 60 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 4.80e-04 | 11 | 60 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.78e-04 | 127 | 60 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | STX18 BRD4 EIF4G1 SMARCA2 NSD1 SMARCA4 DLG1 COL14A1 MPHOSPH8 KAT2A YTHDC1 SPEN | 6.09e-04 | 1356 | 60 | 12 | GO:0060090 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 6.78e-04 | 13 | 60 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | helicase activity | 1.30e-03 | 158 | 60 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | p53 binding | 1.61e-03 | 77 | 60 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 2.16e-03 | 23 | 60 | 2 | GO:0010314 | |
| GeneOntologyMolecularFunction | methylated histone binding | 2.21e-03 | 86 | 60 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | STX18 BRD4 SMARCA2 NSD1 SMARCA4 COL14A1 MPHOSPH8 KAT2A YTHDC1 SPEN | 2.23e-03 | 1160 | 60 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 2.36e-03 | 88 | 60 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | histone reader activity | 2.75e-03 | 26 | 60 | 2 | GO:0140566 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | SUPT6H BRD4 SMARCA2 NSD1 SMARCA4 CHD8 CHD1 MPHOSPH8 ATM KAT2A YTHDC1 DEK | 1.00e-06 | 741 | 59 | 12 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | SUPT6H BRD4 SMARCA2 NSD1 SMARCA4 CHD8 CHD1 MPHOSPH8 ATM KAT2A YTHDC1 DEK | 7.13e-06 | 896 | 59 | 12 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SUPT6H BRD4 SMARCA2 NSD1 SMARCA4 CHD8 CHD1 MPHOSPH8 ATM KAT2A YTHDC1 DEK | 2.12e-05 | 999 | 59 | 12 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | WASHC2C NEXMIF CORO1C BRD4 TNFRSF14 SMARCA2 SMARCA4 DLG1 ATM SPINK5 VEGFA | 5.50e-05 | 927 | 59 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 5.76e-05 | 614 | 59 | 9 | GO:0051249 | |
| GeneOntologyBiologicalProcess | DNA repair | 8.71e-05 | 648 | 59 | 9 | GO:0006281 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 1.05e-04 | 516 | 59 | 8 | GO:1901987 | |
| GeneOntologyBiologicalProcess | protein localization to endosome | 1.14e-04 | 33 | 59 | 3 | GO:0036010 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 1.20e-04 | 6 | 59 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | RPS6KA2 BRD4 EIF4G1 SMARCA2 SMARCA4 DLG1 PRPF19 ATM KAT2A KCNH5 | 1.28e-04 | 845 | 59 | 10 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 1.45e-04 | 402 | 59 | 7 | GO:1901990 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 1.46e-04 | 694 | 59 | 9 | GO:0002694 | |
| GeneOntologyBiologicalProcess | growth | HELT BRD4 EIF4G1 SMARCA2 ANKRD11 SMARCA4 DLG1 COL14A1 EBAG9 ATM KAT2A VEGFA | 1.64e-04 | 1235 | 59 | 12 | GO:0040007 |
| GeneOntologyBiologicalProcess | adaptive immune memory response | 1.67e-04 | 7 | 59 | 2 | GO:0090716 | |
| GeneOntologyBiologicalProcess | embryo development | SUPT6H BRD4 ANKRD11 NSD1 SMARCA4 DLG1 DLG3 POU3F4 CHD8 ATM KAT2A YTHDC1 VEGFA | 1.70e-04 | 1437 | 59 | 13 | GO:0009790 |
| GeneOntologyBiologicalProcess | DNA metabolic process | SUPT6H TRAIP SMARCA2 SMARCA4 PRPF19 BOD1L1 ATM KAT2A HERC2 DEK VEGFA | 2.15e-04 | 1081 | 59 | 11 | GO:0006259 |
| GeneOntologyBiologicalProcess | primitive erythrocyte differentiation | 2.23e-04 | 8 | 59 | 2 | GO:0060319 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | SUPT6H BRD4 ANKRD11 SMARCA4 DLG1 CHD8 ATM KAT2A YTHDC1 VEGFA | 2.26e-04 | 906 | 59 | 10 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SUPT6H BRD4 ANKRD11 SMARCA4 DLG1 CHD8 ATM KAT2A YTHDC1 VEGFA | 2.76e-04 | 929 | 59 | 10 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of cell activation | 2.77e-04 | 756 | 59 | 9 | GO:0050865 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 2.81e-04 | 596 | 59 | 8 | GO:0001701 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 3.20e-04 | 458 | 59 | 7 | GO:0050863 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | HTR1A WASHC2C STX18 RPS6KA2 SMARCA2 SMARCA4 DLG1 MPHOSPH8 ATM KAT2A NEB WASHC2A | 3.52e-04 | 1342 | 59 | 12 | GO:0033043 |
| GeneOntologyBiologicalProcess | DNA damage response | BRD4 TRAIP SMARCA2 SMARCA4 PRPF19 BOD1L1 ATM KAT2A HERC2 DEK | 3.56e-04 | 959 | 59 | 10 | GO:0006974 |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 3.57e-04 | 213 | 59 | 5 | GO:2000045 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 3.57e-04 | 10 | 59 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 3.94e-04 | 627 | 59 | 8 | GO:0044770 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 4.67e-04 | 226 | 59 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex assembly | 4.77e-04 | 227 | 59 | 5 | GO:0031334 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SUPT6H HELT BRD4 SMARCA2 SMARCA4 CHD8 ATM KAT2A CREB3L4 DEK CAVIN2 VEGFA | 4.84e-04 | 1390 | 59 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | primitive hemopoiesis | 5.21e-04 | 12 | 59 | 2 | GO:0060215 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 5.25e-04 | 55 | 59 | 3 | GO:0035886 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF438 ZNF22 HELT SMARCA2 NSD1 SMARCA4 DLG1 CHD8 MPHOSPH8 KAT2A SPEN VEGFA | 5.61e-04 | 1413 | 59 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 5.77e-04 | 362 | 59 | 6 | GO:0010948 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 6.02e-04 | 509 | 59 | 7 | GO:0044772 | |
| GeneOntologyBiologicalProcess | viral transcription | 6.13e-04 | 58 | 59 | 3 | GO:0019083 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 6.86e-04 | 246 | 59 | 5 | GO:1902806 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 7.25e-04 | 249 | 59 | 5 | GO:0035264 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 7.31e-04 | 142 | 59 | 4 | GO:0034728 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 7.39e-04 | 1053 | 59 | 10 | GO:0000122 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 7.72e-04 | 531 | 59 | 7 | GO:0042692 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 9.75e-04 | 266 | 59 | 5 | GO:0045619 | |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | 1.01e-03 | 403 | 59 | 6 | GO:0002440 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 1.06e-03 | 271 | 59 | 5 | GO:0000082 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.06e-03 | 911 | 59 | 9 | GO:0048589 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 1.06e-03 | 17 | 59 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.09e-03 | 158 | 59 | 4 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.10e-03 | 564 | 59 | 7 | GO:0051052 | |
| GeneOntologyCellularComponent | chromatin | FANK1 HELT BRD4 SMARCA2 ANKRD11 NSD1 SMARCA4 POU3F4 CHD8 CHD1 MPHOSPH8 KAT2A CREB3L4 DEK | 5.90e-05 | 1480 | 60 | 14 | GO:0000785 |
| GeneOntologyCellularComponent | bBAF complex | 3.59e-04 | 10 | 60 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SRRM1 SUPT6H CETN3 BRD4 SMARCA2 NSD1 SMARCA4 PRPF19 CHD8 BOD1L1 KAT2A DEK | 4.64e-04 | 1377 | 60 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | npBAF complex | 7.21e-04 | 14 | 60 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 7.21e-04 | 14 | 60 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | WASH complex | 8.30e-04 | 15 | 60 | 2 | GO:0071203 | |
| GeneOntologyCellularComponent | nBAF complex | 9.47e-04 | 16 | 60 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.31e-03 | 75 | 60 | 3 | GO:0035097 | |
| HumanPheno | Attention deficit hyperactivity disorder | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 4.83e-07 | 413 | 23 | 11 | HP:0007018 |
| HumanPheno | Hyperactivity | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 1.15e-06 | 558 | 23 | 12 | HP:0000752 |
| HumanPheno | Short attention span | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 4.60e-06 | 517 | 23 | 11 | HP:0000736 |
| HumanPheno | Reduced attention regulation | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 5.46e-06 | 526 | 23 | 11 | HP:5200044 |
| HumanPheno | Disinhibition | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 8.75e-06 | 807 | 23 | 13 | HP:0000734 |
| HumanPheno | Inappropriate behavior | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 8.75e-06 | 807 | 23 | 13 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 8.75e-06 | 807 | 23 | 13 | HP:5200123 |
| HumanPheno | Social disinhibition | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 8.75e-06 | 807 | 23 | 13 | HP:5200029 |
| HumanPheno | Abnormally increased volition | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 2.02e-05 | 869 | 23 | 13 | HP:5200263 |
| HumanPheno | Diagnostic behavioral phenotype | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 CHD8 CHD1 HERC2 SPEN KCNH5 | 2.58e-05 | 747 | 23 | 12 | HP:0025783 |
| HumanPheno | Abnormal social development | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 3.30e-05 | 908 | 23 | 13 | HP:0025732 |
| HumanPheno | Thick eyebrow | 4.57e-05 | 154 | 23 | 6 | HP:0000574 | |
| HumanPheno | Long philtrum | 5.49e-05 | 429 | 23 | 9 | HP:0000343 | |
| HumanPheno | Autistic behavior | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 SMARCA4 CHD8 CHD1 HERC2 SPEN KCNH5 | 6.33e-05 | 678 | 23 | 11 | HP:0000729 |
| HumanPheno | Sparse, thin scalp hair | 1.16e-04 | 4 | 23 | 2 | HP:0002233 | |
| HumanPheno | Reduced impulse control | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 1.34e-04 | 1032 | 23 | 13 | HP:5200045 |
| HumanPheno | Neuroblastoma | 1.39e-04 | 61 | 23 | 4 | HP:0003006 | |
| HumanPheno | Neuroblastic tumor | 1.39e-04 | 61 | 23 | 4 | HP:0004376 | |
| HumanPheno | Slanting of the palpebral fissure | NEXMIF BRD4 TRAIP SMARCA2 ANKRD11 NSD1 DLG3 CHD8 CHD1 HERC2 SPEN | 1.42e-04 | 739 | 23 | 11 | HP:0200006 |
| HumanPheno | Peripheral primitive neuroectodermal neoplasm | 1.48e-04 | 62 | 23 | 4 | HP:0030067 | |
| HumanPheno | Downslanted palpebral fissures | 1.74e-04 | 497 | 23 | 9 | HP:0000494 | |
| HumanPheno | Primitive neuroectodermal tumor | 2.01e-04 | 67 | 23 | 4 | HP:0030065 | |
| HumanPheno | Abnormal eating behavior | 2.17e-04 | 128 | 23 | 5 | HP:0100738 | |
| HumanPheno | Long eyelashes | 2.25e-04 | 129 | 23 | 5 | HP:0000527 | |
| HumanPheno | Aggressive behavior | 2.33e-04 | 516 | 23 | 9 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 2.33e-04 | 516 | 23 | 9 | HP:0006919 | |
| HumanPheno | Abnormality of the chin | 2.69e-04 | 409 | 23 | 8 | HP:0000306 | |
| HumanPheno | Prominent interphalangeal joints | 2.89e-04 | 6 | 23 | 2 | HP:0006237 | |
| HumanPheno | Abnormality of the frontal hairline | 2.91e-04 | 215 | 23 | 6 | HP:0000599 | |
| HumanPheno | Abnormal fetal physiology | 2.91e-04 | 308 | 23 | 7 | HP:0034059 | |
| HumanPheno | Recurrent hand flapping | 3.02e-04 | 30 | 23 | 3 | HP:0100023 | |
| HumanPheno | Pointed chin | 3.08e-04 | 138 | 23 | 5 | HP:0000307 | |
| HumanPheno | Recurrent maladaptive behavior | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 CHD1 ATM HERC2 SPEN KCNH5 | 3.25e-04 | 1293 | 23 | 14 | HP:5200241 |
| HumanPheno | Delayed speech and language development | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG1 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 3.31e-04 | 1123 | 23 | 13 | HP:0000750 |
| HumanPheno | Thin scalp hair | 3.64e-04 | 143 | 23 | 5 | HP:0002556 | |
| HumanPheno | Thin hair | 3.64e-04 | 143 | 23 | 5 | HP:0002237 | |
| HumanPheno | Sparse scalp hair | 3.64e-04 | 143 | 23 | 5 | HP:0002209 | |
| HumanPheno | Impairment in personality functioning | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 3.91e-04 | 1141 | 23 | 13 | HP:0031466 |
| HumanPheno | Abnormality of the scalp hair | 3.99e-04 | 433 | 23 | 8 | HP:0100037 | |
| HumanPheno | Low anterior hairline | 4.13e-04 | 147 | 23 | 5 | HP:0000294 | |
| HumanPheno | Congenital abnormal hair pattern | 4.21e-04 | 327 | 23 | 7 | HP:0011361 | |
| HumanPheno | Abnormal scalp morphology | 5.19e-04 | 450 | 23 | 8 | HP:0001965 | |
| HumanPheno | Language impairment | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG1 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 5.45e-04 | 1178 | 23 | 13 | HP:0002463 |
| HumanPheno | Prenatal movement abnormality | 6.01e-04 | 246 | 23 | 6 | HP:0001557 | |
| HumanPheno | Hip dysplasia | 6.14e-04 | 247 | 23 | 6 | HP:0001385 | |
| HumanPheno | Abnormal female external genitalia morphology | 6.28e-04 | 161 | 23 | 5 | HP:0000055 | |
| HumanPheno | Delayed skeletal maturation | 6.60e-04 | 352 | 23 | 7 | HP:0002750 | |
| HumanPheno | Thick nasal alae | 6.61e-04 | 39 | 23 | 3 | HP:0009928 | |
| HumanPheno | Neuroepithelial neoplasm | 6.78e-04 | 92 | 23 | 4 | HP:0030063 | |
| HumanPheno | Abnormality of the palpebral fissures | NEXMIF BRD4 TRAIP SMARCA2 ANKRD11 NSD1 DLG3 CHD8 CHD1 HERC2 SPEN | 6.89e-04 | 880 | 23 | 11 | HP:0008050 |
| HumanPheno | Neuroectodermal neoplasm | 7.36e-04 | 94 | 23 | 4 | HP:0030061 | |
| HumanPheno | Nervous tissue neoplasm | 7.36e-04 | 94 | 23 | 4 | HP:0030060 | |
| HumanPheno | Sandal gap | 7.97e-04 | 96 | 23 | 4 | HP:0001852 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 8.62e-04 | 368 | 23 | 7 | HP:0031432 | |
| HumanPheno | Autism | 8.75e-04 | 264 | 23 | 6 | HP:0000717 | |
| HumanPheno | Malignant neoplasm of the central nervous system | 8.95e-04 | 99 | 23 | 4 | HP:0100836 | |
| HumanPheno | Abnormal hip joint morphology | 9.21e-04 | 490 | 23 | 8 | HP:0001384 | |
| HumanPheno | Abnormal hair morphology | NEXMIF BRD4 TRAIP TMC6 SMARCA2 ANKRD11 NSD1 SMARCA4 CHD8 CHD1 ATM HERC2 SPEN SPINK5 | 9.53e-04 | 1424 | 23 | 14 | HP:0001595 |
| HumanPheno | Neoplasm of the central nervous system | 9.92e-04 | 178 | 23 | 5 | HP:0100006 | |
| HumanPheno | Perseverative thought | 9.96e-04 | 377 | 23 | 7 | HP:0030223 | |
| HumanPheno | Broad philtrum | 1.01e-03 | 45 | 23 | 3 | HP:0000289 | |
| HumanPheno | Echolalia | 1.08e-03 | 46 | 23 | 3 | HP:0010529 | |
| HumanPheno | Abnormal synovial membrane morphology | 1.10e-03 | 503 | 23 | 8 | HP:0005262 | |
| HumanPheno | Abnormal motivation | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 1.11e-03 | 1263 | 23 | 13 | HP:5200275 |
| HumanPheno | Abnormal volitional state | NEXMIF BRD4 EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 CHD8 ATM HERC2 SPEN KCNH5 | 1.11e-03 | 1263 | 23 | 13 | HP:0025780 |
| HumanPheno | Disordered formal thought process | 1.15e-03 | 386 | 23 | 7 | HP:0025769 | |
| HumanPheno | Motor stereotypy | 1.19e-03 | 280 | 23 | 6 | HP:0000733 | |
| HumanPheno | Abnormality of the lower urinary tract | NEXMIF BRD4 TRAIP EIF4G1 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG3 NEB SPEN | 1.19e-03 | 937 | 23 | 11 | HP:0010936 |
| HumanPheno | Rib fusion | 1.22e-03 | 48 | 23 | 3 | HP:0000902 | |
| HumanPheno | Abnormal eyelash morphology | 1.28e-03 | 284 | 23 | 6 | HP:0000499 | |
| HumanPheno | Involuntary vocalization | 1.29e-03 | 49 | 23 | 3 | HP:4000074 | |
| HumanPheno | Displacement of the urethral meatus | 1.35e-03 | 397 | 23 | 7 | HP:0100627 | |
| HumanPheno | Abnormal male urethral meatus morphology | 1.39e-03 | 399 | 23 | 7 | HP:0032076 | |
| HumanPheno | Abnormally low-pitched voice | 1.48e-03 | 13 | 23 | 2 | HP:0010300 | |
| HumanPheno | Neoplasm of the nervous system | 1.50e-03 | 195 | 23 | 5 | HP:0004375 | |
| HumanPheno | Abnormal thought pattern | 1.50e-03 | 404 | 23 | 7 | HP:5200269 | |
| HumanPheno | Abnormality of skeletal maturation | 1.52e-03 | 405 | 23 | 7 | HP:0000927 | |
| HumanPheno | Abnormality of the hairline | 1.54e-03 | 294 | 23 | 6 | HP:0009553 | |
| HumanPheno | Narrow nasal bridge | 1.63e-03 | 53 | 23 | 3 | HP:0000446 | |
| HumanPheno | Abnormal consumption behavior | 1.68e-03 | 299 | 23 | 6 | HP:0040202 | |
| HumanPheno | Abnormal eyebrow morphology | 1.71e-03 | 674 | 23 | 9 | HP:0000534 | |
| HumanPheno | Short palm | 1.72e-03 | 118 | 23 | 4 | HP:0004279 | |
| HumanPheno | Abnormal hair pattern | 1.74e-03 | 676 | 23 | 9 | HP:0010720 | |
| HumanPheno | Narrow palate | 1.75e-03 | 202 | 23 | 5 | HP:0000189 | |
| HumanPheno | Abnormal upper lip morphology | NEXMIF BRD4 SMARCA2 ANKRD11 NSD1 SMARCA4 DLG1 CHD8 HERC2 NEB SPEN | 1.76e-03 | 980 | 23 | 11 | HP:0000177 |
| HumanPheno | Highly arched eyebrow | 1.91e-03 | 206 | 23 | 5 | HP:0002553 | |
| HumanPheno | Round face | 1.95e-03 | 122 | 23 | 4 | HP:0000311 | |
| HumanPheno | Curly eyelashes | 1.98e-03 | 15 | 23 | 2 | HP:0007665 | |
| HumanPheno | Steroetypic upper-extremity movements | 2.01e-03 | 57 | 23 | 3 | HP:5200018 | |
| HumanPheno | Basal cell carcinoma | 2.11e-03 | 58 | 23 | 3 | HP:0002671 | |
| HumanPheno | Thin vermilion border | 2.25e-03 | 433 | 23 | 7 | HP:0000233 | |
| Domain | BRK | 6.58e-07 | 6 | 61 | 3 | SM00592 | |
| Domain | BRK_domain | 6.58e-07 | 6 | 61 | 3 | IPR006576 | |
| Domain | BRK | 6.58e-07 | 6 | 61 | 3 | PF07533 | |
| Domain | Bromodomain_CS | 1.46e-06 | 26 | 61 | 4 | IPR018359 | |
| Domain | SNF2_N | 3.46e-06 | 32 | 61 | 4 | IPR000330 | |
| Domain | SNF2_N | 3.46e-06 | 32 | 61 | 4 | PF00176 | |
| Domain | BROMODOMAIN_1 | 6.27e-06 | 37 | 61 | 4 | PS00633 | |
| Domain | Bromodomain | 6.99e-06 | 38 | 61 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 9.53e-06 | 41 | 61 | 4 | PS50014 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 1.05e-05 | 2 | 61 | 2 | IPR014978 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | IPR029295 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | PF14619 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | SM00951 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | PS51666 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | PF08880 | |
| Domain | FAM21 | 1.05e-05 | 2 | 61 | 2 | IPR027308 | |
| Domain | BROMO | 1.05e-05 | 42 | 61 | 4 | SM00297 | |
| Domain | Bromodomain | 1.05e-05 | 42 | 61 | 4 | IPR001487 | |
| Domain | - | 1.05e-05 | 42 | 61 | 4 | 1.20.920.10 | |
| Domain | FAM21/CAPZIP | 3.14e-05 | 3 | 61 | 2 | IPR029341 | |
| Domain | CAP-ZIP_m | 3.14e-05 | 3 | 61 | 2 | PF15255 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | SM00573 | |
| Domain | MAGUK_N_PEST | 6.27e-05 | 4 | 61 | 2 | PF10608 | |
| Domain | PDZ_assoc | 6.27e-05 | 4 | 61 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 6.27e-05 | 4 | 61 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 6.27e-05 | 4 | 61 | 2 | IPR019583 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | PS51204 | |
| Domain | MAGUK_N_PEST | 6.27e-05 | 4 | 61 | 2 | SM01277 | |
| Domain | HSA_dom | 6.27e-05 | 4 | 61 | 2 | IPR014012 | |
| Domain | DLG1 | 6.27e-05 | 4 | 61 | 2 | IPR016313 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | PF07529 | |
| Domain | Chromo_domain | 6.39e-05 | 24 | 61 | 3 | IPR023780 | |
| Domain | Chromo | 8.17e-05 | 26 | 61 | 3 | PF00385 | |
| Domain | CHROMO_1 | 1.02e-04 | 28 | 61 | 3 | PS00598 | |
| Domain | CHROMO_2 | 1.02e-04 | 28 | 61 | 3 | PS50013 | |
| Domain | Chromodomain-like | 1.54e-04 | 32 | 61 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.69e-04 | 33 | 61 | 3 | IPR000953 | |
| Domain | CHROMO | 1.69e-04 | 33 | 61 | 3 | SM00298 | |
| Domain | Helicase_C | 4.13e-04 | 107 | 61 | 4 | PF00271 | |
| Domain | HELICc | 4.13e-04 | 107 | 61 | 4 | SM00490 | |
| Domain | Helicase_C | 4.28e-04 | 108 | 61 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 4.43e-04 | 109 | 61 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.43e-04 | 109 | 61 | 4 | PS51192 | |
| Domain | DEXDc | 4.43e-04 | 109 | 61 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.59e-04 | 110 | 61 | 4 | IPR014001 | |
| Domain | Guanylate_kinase_CS | 1.22e-03 | 16 | 61 | 2 | IPR020590 | |
| Domain | Chromodomain_CS | 1.55e-03 | 18 | 61 | 2 | IPR023779 | |
| Domain | GUANYLATE_KINASE_2 | 2.54e-03 | 23 | 61 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.54e-03 | 23 | 61 | 2 | PS00856 | |
| Domain | Guanylate_kin | 3.24e-03 | 26 | 61 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 3.24e-03 | 26 | 61 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 3.24e-03 | 26 | 61 | 2 | IPR008144 | |
| Domain | GuKc | 3.24e-03 | 26 | 61 | 2 | SM00072 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 5.83e-03 | 35 | 61 | 2 | IPR002464 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 7.11e-05 | 28 | 41 | 3 | M837 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 8.55e-05 | 254 | 41 | 6 | M27131 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.40e-04 | 35 | 41 | 3 | MM15109 | |
| Pathway | REACTOME_NRCAM_INTERACTIONS | 1.72e-04 | 7 | 41 | 2 | M27378 | |
| Pathway | WP_THERMOGENESIS | 2.65e-04 | 108 | 41 | 4 | M39746 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 3.66e-04 | 10 | 41 | 2 | M10272 | |
| Pubmed | STX18 SUPT6H CORO1C RPF2 EIF4G1 SMARCA2 ANKRD11 NSD1 DLG1 DLG3 CHD8 CHD1 MPHOSPH8 KAT2A HERC2 YTHDC1 SPEN CREB3L4 RSBN1L ESF1 | 4.85e-13 | 1497 | 61 | 20 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRM1 BRD4 EIF4G1 ANKRD11 NSD1 SMARCA4 PRPF19 CHD8 CHD1 BOD1L1 MPHOSPH8 SPEN DEK RSBN1L ESF1 | 7.31e-11 | 954 | 61 | 15 | 36373674 |
| Pubmed | SRRM1 SUPT6H RPF2 EIF4G1 SMARCA2 NSD1 SMARCA4 CHD8 CHD1 ATM HERC2 SPEN ESF1 | 9.20e-11 | 653 | 61 | 13 | 22586326 | |
| Pubmed | SRRM1 SUPT6H BRD4 EIF4G1 SMARCA2 SMARCA4 CHD8 CHD1 BOD1L1 MPHOSPH8 ATM KAT2A YTHDC1 DEK ESF1 | 1.70e-10 | 1014 | 61 | 15 | 32416067 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.65e-09 | 283 | 61 | 9 | 30585729 | |
| Pubmed | SRRM1 RPF2 EIF4G1 NMRAL1 DLG1 PRPF19 DLG3 BOD1L1 MPHOSPH8 ATM KAT2A NEB JSRP1 SPEN CAVIN2 ESF1 | 2.44e-09 | 1442 | 61 | 16 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SRRM1 BRD4 NSD1 SMARCA4 CHD8 CHD1 BOD1L1 MPHOSPH8 HERC2 SPEN DEK | 8.08e-09 | 608 | 61 | 11 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 WASHC2C BRD4 EIF4G1 SMARCA2 SMARCA4 DLG1 PATL1 ATM YTHDC1 SPEN ESF1 | 8.71e-09 | 774 | 61 | 12 | 15302935 |
| Pubmed | WASHC2C STX18 NSD1 NADK COL14A1 DLG3 CHD8 CHD1 HERC2 WASHC2A DEK RSBN1L CAVIN2 VEGFA | 1.82e-08 | 1215 | 61 | 14 | 15146197 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.94e-08 | 533 | 61 | 10 | 30554943 | |
| Pubmed | 3.88e-08 | 549 | 61 | 10 | 38280479 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 3.98e-08 | 109 | 61 | 6 | 33554859 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RPS6KA2 BRD4 TMC6 EIF4G1 ANKRD11 NSD1 NADK CHD8 KAT2A HERC2 SPEN WASHC2A PLEKHG5 | 5.00e-08 | 1105 | 61 | 13 | 35748872 |
| Pubmed | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | 5.12e-08 | 5 | 61 | 3 | 26626481 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SUPT6H CORO1C RPF2 SMARCA4 PRPF19 CHD1 BOD1L1 MPHOSPH8 YTHDC1 DEK RSBN1L ESF1 | 1.26e-07 | 989 | 61 | 12 | 36424410 |
| Pubmed | 1.27e-07 | 469 | 61 | 9 | 27634302 | ||
| Pubmed | SRRM1 STX18 SUPT6H RPF2 ANKRD11 DLG1 PRPF19 COL14A1 CHD1 ATM HERC2 WASHC2A DEK ESF1 | 2.19e-07 | 1487 | 61 | 14 | 33957083 | |
| Pubmed | SRRM1 WASHC2C CORO1C RPF2 EIF4G1 SMARCA4 PRPF19 CHD1 YTHDC1 DEK CAVIN2 | 2.31e-07 | 847 | 61 | 11 | 35850772 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRRM1 SUPT6H BRD4 RPF2 EIF4G1 SMARCA4 PRPF19 MPHOSPH8 ATM YTHDC1 SPEN DEK | 3.31e-07 | 1082 | 61 | 12 | 38697112 |
| Pubmed | KIF21B SRRM1 SLC22A23 BRD4 EIF4G1 ANKRD11 CHD8 CHD1 MPHOSPH8 PATL1 KAT2A CAVIN2 ESF1 | 4.09e-07 | 1327 | 61 | 13 | 32694731 | |
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 11839798 | ||
| Pubmed | 8.54e-07 | 183 | 61 | 6 | 36129980 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SUPT6H CORO1C RPF2 EIF4G1 SMARCA4 PRPF19 CHD1 BOD1L1 MPHOSPH8 ATM SPEN DEK ESF1 | 9.10e-07 | 1425 | 61 | 13 | 30948266 |
| Pubmed | 1.08e-06 | 103 | 61 | 5 | 32744500 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SRRM1 SUPT6H CORO1C RPF2 EIF4G1 SMARCA4 PRPF19 CHD1 HERC2 SPEN DEK | 1.49e-06 | 1024 | 61 | 11 | 24711643 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRRM1 SUPT6H BRD4 ANKRD11 NSD1 SMARCA4 PRPF19 MPHOSPH8 KAT2A YTHDC1 SPEN DEK | 2.16e-06 | 1294 | 61 | 12 | 30804502 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SRRM1 RPF2 EIF4G1 SMARCA2 SMARCA4 PRPF19 CHD8 CHD1 PATL1 YTHDC1 DEK RSBN1L | 2.61e-06 | 1318 | 61 | 12 | 30463901 |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 8670841 | ||
| Pubmed | BRG1 promotes VEGF-A expression and angiogenesis in human colorectal cancer cells. | 3.03e-06 | 2 | 61 | 2 | 28899659 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 3.03e-06 | 2 | 61 | 2 | 23076393 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15576411 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15240517 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 3.03e-06 | 2 | 61 | 2 | 33027072 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23872584 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 3.03e-06 | 2 | 61 | 2 | 23088494 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20333683 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 34812766 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 3.03e-06 | 2 | 61 | 2 | 30478150 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25408355 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 31937753 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20827171 | ||
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 3.03e-06 | 2 | 61 | 2 | 25808524 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 3.03e-06 | 2 | 61 | 2 | 19144648 | |
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 3.03e-06 | 2 | 61 | 2 | 36717248 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 3.03e-06 | 2 | 61 | 2 | 29391527 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 37634210 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 8208605 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 3.03e-06 | 2 | 61 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 3.03e-06 | 2 | 61 | 2 | 12620226 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27039070 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 29848589 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 3.03e-06 | 2 | 61 | 2 | 9603422 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23276717 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27097303 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15847701 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28038711 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 3.03e-06 | 2 | 61 | 2 | 23963727 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 3.03e-06 | 2 | 61 | 2 | 31375262 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17075831 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 3.03e-06 | 2 | 61 | 2 | 32855269 | |
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 3.03e-06 | 2 | 61 | 2 | 22721696 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18508913 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11719516 | ||
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 3.03e-06 | 2 | 61 | 2 | 28706277 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21092585 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26551623 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19458193 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 34289068 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 34518526 | ||
| Pubmed | Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. | 3.03e-06 | 2 | 61 | 2 | 34375583 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 32312722 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26356327 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12566296 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18618587 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 31406271 | ||
| Pubmed | Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits. | 3.03e-06 | 2 | 61 | 2 | 29273066 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | WASHC2C CETN3 CORO1C EIF4G1 SMARCA2 SMARCA4 PRPF19 PATL1 ATM HERC2 WASHC2A | 4.72e-06 | 1155 | 61 | 11 | 20360068 |
| Pubmed | CORO1C EIF4G1 SMARCA2 SMARCA4 PRPF19 CHD8 GIGYF1 PATL1 KAT2A HERC2 SPEN WASHC2A | 5.95e-06 | 1429 | 61 | 12 | 35140242 | |
| Pubmed | KIF21B CORO1C RPS6KA2 EIF4G1 NSD1 SMARCA4 DLG1 DLG3 CHD8 HERC2 | 6.34e-06 | 963 | 61 | 10 | 28671696 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 7.62e-06 | 71 | 61 | 4 | 28319113 | |
| Pubmed | 8.53e-06 | 157 | 61 | 5 | 30186101 | ||
| Pubmed | 8.87e-06 | 23 | 61 | 3 | 31748650 | ||
| Pubmed | DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1. | 9.07e-06 | 3 | 61 | 2 | 30287812 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26988756 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 15034933 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12044884 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21518954 | ||
| Pubmed | Characterization of mammary tumors from Brg1 heterozygous mice. | 9.07e-06 | 3 | 61 | 2 | 17637742 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12175853 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 25268382 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 28292935 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 36464671 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 37428639 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 38970714 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 17938176 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 22740088 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 34292326 | ||
| Interaction | SIRT7 interactions | SRRM1 SUPT6H BRD4 RPF2 EIF4G1 SMARCA2 NSD1 SMARCA4 CHD8 CHD1 ATM HERC2 SPEN ESF1 | 3.48e-08 | 744 | 61 | 14 | int:SIRT7 |
| Interaction | NSD3 interactions | 6.24e-08 | 117 | 61 | 7 | int:NSD3 | |
| Interaction | SMC5 interactions | SRRM1 BRD4 EIF4G1 ANKRD11 NSD1 SMARCA4 PRPF19 CHD8 CHD1 BOD1L1 MPHOSPH8 SPEN DEK RSBN1L ESF1 | 2.02e-07 | 1000 | 61 | 15 | int:SMC5 |
| Interaction | H3C3 interactions | SRRM1 SUPT6H BRD4 NSD1 SMARCA4 CHD8 CHD1 BOD1L1 MPHOSPH8 SPEN DEK | 2.42e-07 | 495 | 61 | 11 | int:H3C3 |
| Interaction | H3-3A interactions | CORO1C BRD4 NSD1 SMARCA4 CHD8 CHD1 BOD1L1 MPHOSPH8 KAT2A HERC2 SPEN CREB3L4 DEK | 2.94e-07 | 749 | 61 | 13 | int:H3-3A |
| Interaction | H3C1 interactions | BRD4 EIF4G1 SMARCA2 NSD1 SMARCA4 CHD8 CHD1 MPHOSPH8 ATM KAT2A NEB SPEN DEK RSBN1L | 3.65e-07 | 901 | 61 | 14 | int:H3C1 |
| Interaction | BMI1 interactions | SRRM1 SUPT6H BRD4 EIF4G1 SMARCA2 NSD1 SMARCA4 MPHOSPH8 ATM YTHDC1 SPEN DEK | 5.43e-07 | 659 | 61 | 12 | int:BMI1 |
| Interaction | KPNA3 interactions | 7.88e-07 | 248 | 61 | 8 | int:KPNA3 | |
| Interaction | TWIST1 interactions | 7.99e-07 | 170 | 61 | 7 | int:TWIST1 | |
| Interaction | ZNF330 interactions | SUPT6H ANKRD11 NSD1 SMARCA4 CHD1 MPHOSPH8 YTHDC1 DEK RSBN1L ESF1 | 8.38e-07 | 446 | 61 | 10 | int:ZNF330 |
| Interaction | MEN1 interactions | SRRM1 WASHC2C RPF2 EIF4G1 SMARCA4 PRPF19 CHD8 CHD1 BOD1L1 YTHDC1 SPEN DEK RSBN1L CAVIN2 | 1.78e-06 | 1029 | 61 | 14 | int:MEN1 |
| Interaction | OBSL1 interactions | SRRM1 ZNF22 SUPT6H CORO1C RPF2 SMARCA4 PRPF19 CHD1 HERC2 YTHDC1 SPEN DEK RSBN1L | 2.37e-06 | 902 | 61 | 13 | int:OBSL1 |
| Interaction | NUP43 interactions | SRRM1 SUPT6H EIF4G1 ANKRD11 NSD1 SMARCA4 CHD8 CHD1 BOD1L1 YTHDC1 SPEN | 2.39e-06 | 625 | 61 | 11 | int:NUP43 |
| Interaction | APEX1 interactions | SRRM1 BRD4 EIF4G1 NMRAL1 ANKRD11 NSD1 SMARCA4 PRPF19 EBAG9 ATM YTHDC1 DEK PLEKHG5 RSBN1L VEGFA | 4.11e-06 | 1271 | 61 | 15 | int:APEX1 |
| Interaction | MECP2 interactions | SRRM1 SUPT6H BRD4 RPF2 EIF4G1 SMARCA2 NSD1 SMARCA4 PRPF19 MPHOSPH8 ATM YTHDC1 SPEN DEK ESF1 | 4.79e-06 | 1287 | 61 | 15 | int:MECP2 |
| Interaction | SSRP1 interactions | SRRM1 ZNF22 SUPT6H BRD4 ANKRD11 SMARCA4 PRPF19 CHD1 MPHOSPH8 YTHDC1 CAVIN2 | 5.74e-06 | 685 | 61 | 11 | int:SSRP1 |
| Interaction | NUP50 interactions | 8.35e-06 | 341 | 61 | 8 | int:NUP50 | |
| Interaction | DHX40 interactions | 9.98e-06 | 249 | 61 | 7 | int:DHX40 | |
| Interaction | KPNA1 interactions | 1.03e-05 | 351 | 61 | 8 | int:KPNA1 | |
| Interaction | NPM1 interactions | ZNF22 BRD4 RPF2 EIF4G1 NMRAL1 NSD1 SMARCA4 CHD8 CHD1 ATM NEB RSBN1L CAVIN2 ESF1 | 1.06e-05 | 1201 | 61 | 14 | int:NPM1 |
| Interaction | SOX9 interactions | 1.12e-05 | 97 | 61 | 5 | int:SOX9 | |
| Interaction | KIF20A interactions | ZNF438 SRRM1 SUPT6H CORO1C BRD4 SMARCA2 SMARCA4 PRPF19 CHD8 CHD1 BOD1L1 HERC2 DEK | 1.26e-05 | 1052 | 61 | 13 | int:KIF20A |
| Interaction | EIF3I interactions | 1.26e-05 | 258 | 61 | 7 | int:EIF3I | |
| Interaction | RNF40 interactions | 1.35e-05 | 261 | 61 | 7 | int:RNF40 | |
| Interaction | POLR1G interactions | 1.53e-05 | 489 | 61 | 9 | int:POLR1G | |
| Interaction | BRD3 interactions | 1.66e-05 | 494 | 61 | 9 | int:BRD3 | |
| Interaction | SNRNP40 interactions | SRRM1 SUPT6H BRD4 NMRAL1 SMARCA4 PRPF19 CHD1 YTHDC1 SPEN RSBN1L | 1.95e-05 | 637 | 61 | 10 | int:SNRNP40 |
| Interaction | CIT interactions | SRRM1 SUPT6H CORO1C RPF2 EIF4G1 SMARCA2 SMARCA4 PRPF19 CHD8 CHD1 BOD1L1 MPHOSPH8 DEK RSBN1L ESF1 | 2.00e-05 | 1450 | 61 | 15 | int:CIT |
| Interaction | CBX3 interactions | 2.20e-05 | 646 | 61 | 10 | int:CBX3 | |
| Interaction | PARP1 interactions | SRRM1 SUPT6H CORO1C BRD4 TRAIP SMARCA2 NSD1 SMARCA4 PRPF19 CHD1 ATM YTHDC1 RSBN1L ESF1 | 2.96e-05 | 1316 | 61 | 14 | int:PARP1 |
| Interaction | MDC1 interactions | 3.37e-05 | 414 | 61 | 8 | int:MDC1 | |
| Interaction | BAZ1B interactions | 3.49e-05 | 204 | 61 | 6 | int:BAZ1B | |
| Interaction | ABT1 interactions | 3.92e-05 | 423 | 61 | 8 | int:ABT1 | |
| Interaction | TERF2IP interactions | 3.97e-05 | 552 | 61 | 9 | int:TERF2IP | |
| Interaction | RNPS1 interactions | 4.06e-05 | 425 | 61 | 8 | int:RNPS1 | |
| Interaction | TOP1 interactions | SRRM1 SUPT6H BRD4 TRAIP SMARCA4 PRPF19 MPHOSPH8 ATM HERC2 YTHDC1 | 4.15e-05 | 696 | 61 | 10 | int:TOP1 |
| Interaction | H2BC21 interactions | 4.15e-05 | 696 | 61 | 10 | int:H2BC21 | |
| Interaction | NIFK interactions | 4.48e-05 | 431 | 61 | 8 | int:NIFK | |
| Interaction | RBM25 interactions | 5.29e-05 | 323 | 61 | 7 | int:RBM25 | |
| Interaction | H2BC8 interactions | 5.51e-05 | 576 | 61 | 9 | int:H2BC8 | |
| Interaction | CDK8 interactions | 5.59e-05 | 222 | 61 | 6 | int:CDK8 | |
| Interaction | H2AX interactions | 6.89e-05 | 593 | 61 | 9 | int:H2AX | |
| Interaction | KIF13B interactions | 7.01e-05 | 142 | 61 | 5 | int:KIF13B | |
| Interaction | HDAC4 interactions | SRRM1 WASHC2C TNFRSF14 ANKRD11 NADK CHD8 GIGYF1 ATM HERC2 CAVIN2 | 7.26e-05 | 744 | 61 | 10 | int:HDAC4 |
| Interaction | GTF2F1 interactions | 7.49e-05 | 234 | 61 | 6 | int:GTF2F1 | |
| Interaction | SREBF1 interactions | 9.09e-05 | 150 | 61 | 5 | int:SREBF1 | |
| Interaction | YAP1 interactions | CORO1C BRD4 SMARCA2 NSD1 SMARCA4 DLG1 CHD8 CHD1 BOD1L1 SPEN RSBN1L ESF1 | 9.16e-05 | 1095 | 61 | 12 | int:YAP1 |
| Interaction | XRCC6 interactions | CORO1C BRD4 NSD1 SMARCA4 PRPF19 CHD8 BOD1L1 KAT2A SPEN RSBN1L ESF1 | 9.40e-05 | 928 | 61 | 11 | int:XRCC6 |
| Interaction | DDX23 interactions | 9.51e-05 | 480 | 61 | 8 | int:DDX23 | |
| Interaction | TAF6 interactions | 9.64e-05 | 245 | 61 | 6 | int:TAF6 | |
| Interaction | TOP3B interactions | RPS6KA2 BRD4 TMC6 EIF4G1 ANKRD11 NSD1 NADK CHD8 PATL1 KAT2A HERC2 SPEN WASHC2A PLEKHG5 | 9.86e-05 | 1470 | 61 | 14 | int:TOP3B |
| Interaction | BRDT interactions | 1.06e-04 | 81 | 61 | 4 | int:BRDT | |
| Interaction | CREB1 interactions | 1.17e-04 | 254 | 61 | 6 | int:CREB1 | |
| Interaction | NCL interactions | SRRM1 SUPT6H BRD4 TRAIP RAB11FIP2 RPF2 SMARCA4 PRPF19 HERC2 DEK | 1.29e-04 | 798 | 61 | 10 | int:NCL |
| Interaction | KHDRBS1 interactions | 1.30e-04 | 373 | 61 | 7 | int:KHDRBS1 | |
| Interaction | TAF1 interactions | 1.33e-04 | 260 | 61 | 6 | int:TAF1 | |
| Interaction | XPA interactions | 1.34e-04 | 86 | 61 | 4 | int:XPA | |
| Interaction | DDX41 interactions | 1.46e-04 | 166 | 61 | 5 | int:DDX41 | |
| Interaction | H1-2 interactions | 1.66e-04 | 666 | 61 | 9 | int:H1-2 | |
| Interaction | TIMP4 interactions | 1.87e-04 | 7 | 61 | 2 | int:TIMP4 | |
| Interaction | ZMYND11 interactions | 1.89e-04 | 94 | 61 | 4 | int:ZMYND11 | |
| Interaction | ADAMTS1 interactions | 1.97e-04 | 95 | 61 | 4 | int:ADAMTS1 | |
| Interaction | NUPR1 interactions | 2.01e-04 | 683 | 61 | 9 | int:NUPR1 | |
| Interaction | POLR2A interactions | 2.03e-04 | 536 | 61 | 8 | int:POLR2A | |
| Interaction | ZNF467 interactions | 2.08e-04 | 179 | 61 | 5 | int:ZNF467 | |
| Interaction | SMC3 interactions | 2.25e-04 | 408 | 61 | 7 | int:SMC3 | |
| Interaction | VTN interactions | 2.30e-04 | 183 | 61 | 5 | int:VTN | |
| Interaction | GATA4 interactions | 2.36e-04 | 411 | 61 | 7 | int:GATA4 | |
| Interaction | ACTL6A interactions | 2.37e-04 | 289 | 61 | 6 | int:ACTL6A | |
| Interaction | SRSF2 interactions | 2.41e-04 | 290 | 61 | 6 | int:SRSF2 | |
| Interaction | COIL interactions | 2.47e-04 | 552 | 61 | 8 | int:COIL | |
| Interaction | ENY2 interactions | 2.48e-04 | 186 | 61 | 5 | int:ENY2 | |
| Interaction | MCPH1 interactions | 2.49e-04 | 101 | 61 | 4 | int:MCPH1 | |
| Interaction | AP3B1 interactions | 2.55e-04 | 187 | 61 | 5 | int:AP3B1 | |
| Interaction | SNIP1 interactions | 2.57e-04 | 417 | 61 | 7 | int:SNIP1 | |
| Interaction | DNAJC9 interactions | 2.69e-04 | 296 | 61 | 6 | int:DNAJC9 | |
| Interaction | BRD2 interactions | 3.05e-04 | 429 | 61 | 7 | int:BRD2 | |
| Interaction | NOP56 interactions | 3.07e-04 | 570 | 61 | 8 | int:NOP56 | |
| Interaction | CLK2 interactions | 3.09e-04 | 195 | 61 | 5 | int:CLK2 | |
| Interaction | ARHGEF26 interactions | 3.20e-04 | 44 | 61 | 3 | int:ARHGEF26 | |
| Interaction | EED interactions | SRRM1 SUPT6H CORO1C BRD4 RPF2 EIF4G1 SMARCA2 NSD1 SMARCA4 PRPF19 HERC2 SPEN DEK | 3.21e-04 | 1445 | 61 | 13 | int:EED |
| Interaction | FUBP1 interactions | 3.38e-04 | 309 | 61 | 6 | int:FUBP1 | |
| Interaction | E2F1 interactions | 3.47e-04 | 200 | 61 | 5 | int:E2F1 | |
| Interaction | SNRPC interactions | 3.56e-04 | 440 | 61 | 7 | int:SNRPC | |
| Interaction | MED17 interactions | 3.63e-04 | 202 | 61 | 5 | int:MED17 | |
| Interaction | SRSF11 interactions | 3.72e-04 | 203 | 61 | 5 | int:SRSF11 | |
| Interaction | SCN5A interactions | 3.89e-04 | 47 | 61 | 3 | int:SCN5A | |
| Interaction | H3-3B interactions | 3.95e-04 | 114 | 61 | 4 | int:H3-3B | |
| Interaction | USP37 interactions | 4.09e-04 | 115 | 61 | 4 | int:USP37 | |
| Interaction | PRP4K interactions | 4.72e-04 | 329 | 61 | 6 | int:PRP4K | |
| Interaction | CHD4 interactions | SRRM1 SUPT6H BRD4 EIF4G1 SMARCA2 SMARCA4 PRPF19 ATM SPEN DEK | 4.73e-04 | 938 | 61 | 10 | int:CHD4 |
| Interaction | SRRM2 interactions | 4.77e-04 | 462 | 61 | 7 | int:SRRM2 | |
| Interaction | RNF20 interactions | 4.93e-04 | 216 | 61 | 5 | int:RNF20 | |
| Interaction | UBR4 interactions | 5.11e-04 | 334 | 61 | 6 | int:UBR4 | |
| Interaction | GMNN interactions | 5.11e-04 | 122 | 61 | 4 | int:GMNN | |
| Interaction | MLLT1 interactions | 5.27e-04 | 123 | 61 | 4 | int:MLLT1 | |
| Interaction | SMARCAL1 interactions | 5.55e-04 | 53 | 61 | 3 | int:SMARCAL1 | |
| Interaction | CSNK2B interactions | 5.66e-04 | 625 | 61 | 8 | int:CSNK2B | |
| Interaction | PURG interactions | 5.70e-04 | 223 | 61 | 5 | int:PURG | |
| Interaction | ABI1 interactions | 5.70e-04 | 223 | 61 | 5 | int:ABI1 | |
| Cytoband | 8q23 | 2.62e-04 | 18 | 61 | 2 | 8q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 2.04e-03 | 188 | 61 | 3 | chr10q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 2.12e-03 | 681 | 61 | 5 | chr1p36 | |
| GeneFamily | WASH complex | 7.12e-05 | 6 | 40 | 2 | 1331 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.50e-03 | 26 | 40 | 2 | 904 | |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_UP | 1.33e-05 | 223 | 61 | 6 | M11383 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.77e-05 | 523 | 61 | 8 | M12707 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 3.21e-05 | 534 | 61 | 8 | MM1054 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP | 5.97e-05 | 178 | 61 | 5 | M8996 | |
| Coexpression | GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN | 9.19e-05 | 195 | 61 | 5 | M5445 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP | 9.41e-05 | 196 | 61 | 5 | M6063 | |
| Coexpression | GSE3039_B2_VS_B1_BCELL_UP | 1.01e-04 | 199 | 61 | 5 | M6450 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP | 1.01e-04 | 199 | 61 | 5 | M5213 | |
| Coexpression | GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP | 1.03e-04 | 200 | 61 | 5 | M8514 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP | 1.03e-04 | 200 | 61 | 5 | M3865 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.35e-04 | 656 | 61 | 8 | M18979 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B TMC6 SMARCA2 ANKRD11 NSD1 CHD1 BOD1L1 MPHOSPH8 ATM YTHDC1 SPEN DEK | 1.43e-04 | 1492 | 61 | 12 | M40023 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | RPF2 NMRAL1 DLG1 PRPF19 EBAG9 CHD1 MPHOSPH8 ATM KAT2A DEK ESF1 KCNH5 | 8.43e-05 | 1164 | 60 | 12 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | KIF21B SRRM1 ZNF22 BRD4 NSD1 EBAG9 CHD1 BOD1L1 MPHOSPH8 ATM DEK ESF1 KCNH5 | 9.46e-05 | 1370 | 60 | 13 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.20e-04 | 532 | 60 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SRRM1 ZNF22 BRD4 RPF2 NSD1 EBAG9 CHD1 BOD1L1 MPHOSPH8 ATM DEK ESF1 | 1.74e-04 | 1257 | 60 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SRRM1 ZNF22 BRD4 RPF2 TNFRSF14 NSD1 EBAG9 CHD1 BOD1L1 MPHOSPH8 ATM DEK ESF1 | 1.78e-04 | 1459 | 60 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.79e-04 | 564 | 60 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.77e-04 | 204 | 60 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.17e-04 | 210 | 60 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | RPF2 NMRAL1 DLG1 PRPF19 EBAG9 CHD1 MPHOSPH8 ATM KAT2A DEK ESF1 KCNH5 | 3.30e-04 | 1347 | 60 | 12 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ZNF438 SRRM1 NEXMIF RAB11FIP2 EIF4G1 ANKRD11 SMARCA4 CHD8 ESF1 | 3.69e-04 | 795 | 60 | 9 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SRRM1 RAB11FIP2 EIF4G1 SMARCA2 ANKRD11 COL14A1 CHD8 CAVIN2 ESF1 | 3.75e-04 | 797 | 60 | 9 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | SRRM1 BRD4 RPF2 NMRAL1 DLG3 EBAG9 CHD1 MPHOSPH8 ATM KAT2A DEK ESF1 | 3.87e-04 | 1371 | 60 | 12 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.06e-07 | 198 | 61 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.15e-07 | 199 | 61 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.31e-06 | 138 | 61 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 178 | 61 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-06 | 188 | 61 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 195 | 61 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 7.46e-06 | 197 | 61 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.64e-06 | 198 | 61 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.64e-06 | 198 | 61 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 7.83e-06 | 199 | 61 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 7.83e-06 | 199 | 61 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.83e-06 | 199 | 61 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-06 | 200 | 61 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.02e-06 | 200 | 61 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-06 | 200 | 61 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.02e-06 | 200 | 61 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.89e-05 | 115 | 61 | 4 | cc2f8fb0cbb72b241b65a69195aac0507bddf2e2 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Treg|World / disease group, cell group and cell class (v2) | 4.68e-05 | 145 | 61 | 4 | a3b0e1d0ce0caa8b281a146439d6455db64cc3e5 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.86e-05 | 160 | 61 | 4 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.03e-05 | 161 | 61 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.71e-05 | 175 | 61 | 4 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 184 | 61 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 184 | 61 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 187 | 61 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 190 | 61 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.39e-04 | 192 | 61 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 194 | 61 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 195 | 61 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.53e-04 | 197 | 61 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.53e-04 | 197 | 61 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 198 | 61 | 4 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.56e-04 | 198 | 61 | 4 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.59e-04 | 199 | 61 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.59e-04 | 199 | 61 | 4 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.59e-04 | 199 | 61 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.59e-04 | 199 | 61 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.59e-04 | 199 | 61 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.59e-04 | 199 | 61 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.62e-04 | 200 | 61 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.62e-04 | 200 | 61 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.62e-04 | 200 | 61 | 4 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.62e-04 | 200 | 61 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 1.62e-04 | 200 | 61 | 4 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| Drug | Iohexol [66108-95-0]; Down 200; 4.8uM; HL60; HT_HG-U133A | 7.01e-07 | 188 | 61 | 7 | 2461_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.59e-07 | 197 | 61 | 7 | 3433_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.90e-06 | 177 | 61 | 6 | 985_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.33e-05 | 194 | 61 | 6 | 5674_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 61 | 6 | 1536_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 61 | 6 | 6826_DN | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 61 | 6 | 6221_DN | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.05e-05 | 5 | 60 | 2 | C3281201 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 9.31e-05 | 43 | 60 | 3 | DOID:9261 (is_marker_for) | |
| Disease | Memory Loss | 9.31e-05 | 43 | 60 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 9.31e-05 | 43 | 60 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 9.31e-05 | 43 | 60 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 9.31e-05 | 43 | 60 | 3 | C0751293 | |
| Disease | Memory Disorders | 9.31e-05 | 43 | 60 | 3 | C0025261 | |
| Disease | Memory impairment | 9.98e-05 | 44 | 60 | 3 | C0233794 | |
| Disease | cutaneous melanoma | 1.10e-04 | 121 | 60 | 4 | EFO_0000389 | |
| Disease | benign neoplasm (implicated_via_orthology) | 1.13e-04 | 8 | 60 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.38e-04 | 49 | 60 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.45e-04 | 9 | 60 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.81e-04 | 10 | 60 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | cancer (implicated_via_orthology) | 2.16e-04 | 268 | 60 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.47e-04 | 616 | 60 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.47e-04 | 616 | 60 | 7 | C0376358 | |
| Disease | Coffin-Siris syndrome | 3.13e-04 | 13 | 60 | 2 | C0265338 | |
| Disease | squamous cell carcinoma | 3.49e-04 | 67 | 60 | 3 | EFO_0000707 | |
| Disease | household income | 3.86e-04 | 304 | 60 | 5 | EFO_0009695 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 5.42e-04 | 17 | 60 | 2 | OBA_2045173 | |
| Disease | skin sensitivity to sun | 6.80e-04 | 19 | 60 | 2 | EFO_0004795 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 6.80e-04 | 19 | 60 | 2 | C1333991 | |
| Disease | inosine measurement | 6.80e-04 | 19 | 60 | 2 | EFO_0010503 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 6.80e-04 | 19 | 60 | 2 | C2936783 | |
| Disease | creatinine measurement | 8.80e-04 | 995 | 60 | 8 | EFO_0004518 | |
| Disease | diet measurement, fasting blood insulin measurement | 9.15e-04 | 22 | 60 | 2 | EFO_0004466, EFO_0008111 | |
| Disease | sunburn | 9.98e-04 | 96 | 60 | 3 | EFO_0003958 | |
| Disease | diet measurement, HOMA-IR | 1.00e-03 | 23 | 60 | 2 | EFO_0004501, EFO_0008111 | |
| Disease | Adenoid Cystic Carcinoma | 1.12e-03 | 100 | 60 | 3 | C0010606 | |
| Disease | mean reticulocyte volume | 1.15e-03 | 799 | 60 | 7 | EFO_0010701 | |
| Disease | suntan | 1.22e-03 | 103 | 60 | 3 | EFO_0004279 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.28e-03 | 26 | 60 | 2 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.38e-03 | 27 | 60 | 2 | C1112155 | |
| Disease | Epilepsy | 1.44e-03 | 109 | 60 | 3 | C0014544 | |
| Disease | response to quetiapine | 1.49e-03 | 28 | 60 | 2 | GO_0097335 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.49e-03 | 28 | 60 | 2 | DOID:8634 (is_marker_for) | |
| Disease | Developmental Academic Disorder | 1.59e-03 | 29 | 60 | 2 | C1330966 | |
| Disease | Learning Disorders | 1.59e-03 | 29 | 60 | 2 | C0023186 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.59e-03 | 29 | 60 | 2 | C1333990 | |
| Disease | Learning Disturbance | 1.59e-03 | 29 | 60 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 1.59e-03 | 29 | 60 | 2 | C0751262 | |
| Disease | Learning Disabilities | 1.59e-03 | 29 | 60 | 2 | C0751265 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVRPEEEGEKKRRKK | 491 | Q9HCK8 | |
| ERKRIKKEPVTRKAG | 81 | Q6UB99 | |
| RKKRKPQAEKVDVIA | 676 | O60885 | |
| IRKPDLKVRCIKVQK | 121 | Q4VNC1 | |
| RVEKKERARLKTVKF | 646 | Q12959 | |
| TASKDKKVRVIDPRK | 191 | Q9ULV4 | |
| RRVKKDVEKSLPAKV | 696 | O14646 | |
| TIRKTQKIVIKKREP | 101 | O00559 | |
| TTKIFDKPRKRKRQR | 1461 | Q96L73 | |
| KFRVEKDKLVPEKRT | 336 | Q92830 | |
| LKFRSEERPVKKRKV | 196 | Q6ZTZ1 | |
| KEKQVRDKRRKTLVI | 511 | Q86TB9 | |
| KERKRTPVSHKVIEK | 6 | A6NFD8 | |
| RPIRKKTEEEEKLLK | 876 | O75420 | |
| RKEKPRKEERPKKER | 246 | Q96MG2 | |
| KVRVVTRNPRKKAAK | 31 | Q9HBL8 | |
| IAQKIIRERRKKRVP | 1546 | O95714 | |
| IRERRKKRVPKKPES | 1551 | O95714 | |
| AKEKERAEPRAKVKR | 611 | Q9NQ38 | |
| RKRIIFRKISDVKKE | 671 | Q8NCM2 | |
| PEKDRKVKIDKRFRA | 26 | Q9H501 | |
| KVRVVKELRGKKTAV | 241 | O95544 | |
| LKKKEVRQRRKSPEK | 551 | O75037 | |
| VEEEVKTRKPKKKTR | 276 | Q9UHL3 | |
| GRKRKKRTSIEVSVK | 276 | P49335 | |
| ERKKRGKTVPEELVK | 186 | Q9UMS4 | |
| PKAARIKEVLKERKV | 551 | Q8NFC6 | |
| TERKKEVEKFKRLIR | 21 | Q13315 | |
| EKRKDPKPRVKVVDR | 121 | Q05707 | |
| SLIVEGKREKKKVER | 51 | P35659 | |
| KTIKRKIAPVKRGED | 836 | Q9HC77 | |
| AARFRIRKTVKKVEK | 221 | P08908 | |
| RSELVVDKTKRKKRR | 6 | O15182 | |
| IPSKKRVEKKERARL | 561 | Q92796 | |
| RVEKKERARLKTVKF | 566 | Q92796 | |
| QVAVSVPKRRRKIKE | 506 | Q04637 | |
| VPKRRRKIKELNKKE | 511 | Q04637 | |
| KIVSVERREKIKKSL | 261 | O95810 | |
| TKAEERVLKKVRRKI | 211 | Q8TEY5 | |
| VRGRRKKKTPRKAED | 326 | Q99549 | |
| VVSLLEERKKKQRPK | 326 | Q8TC84 | |
| SAKKVRTEEKKAPRR | 41 | Q6PCB5 | |
| ELIRKPVDFKKIKER | 1441 | P51531 | |
| EKELSRRPKKVCIVK | 406 | A1A5C7 | |
| KKRRKVTRKEPPVII | 526 | Q5QGS0 | |
| IRKPVDFKKIKERIR | 1501 | P51532 | |
| RVVKPKTKRAKRFLE | 6 | Q9H7B2 | |
| KTKRAKRFLEKREPK | 11 | Q9H7B2 | |
| IRVRPKKTTKKRVSR | 251 | Q7KZ85 | |
| KAVKKAERTRVIRPP | 616 | O94827 | |
| ERKPVRKEILKRESK | 1036 | Q96T58 | |
| RVKRVVDKKRLSKLE | 156 | Q9P2W9 | |
| IRRVSRTPEPKKIKK | 721 | Q8IYB3 | |
| EAKPRKTLKEKKERR | 316 | Q9Y4E1 | |
| PNKERREAVKLKITK | 91 | Q9Y6S9 | |
| KPIEIRKENKREKRE | 341 | Q7L804 | |
| EKKKERKRARGISPI | 296 | Q96MU7 | |
| EAKPRKTLKEKKERR | 316 | Q641Q2 | |
| EEKPRKTRGKNIRVK | 191 | P17026 | |
| KRRKPRGDVVKVIVS | 226 | Q92956 | |
| EKKLKRRRKPEFDIA | 576 | Q7Z403 | |
| RPKKDRARQEKKSVR | 131 | P15692 | |
| KRKGRKRKVPDEILA | 381 | Q7Z4V0 | |
| KPKTKVKQRVRVKTV | 441 | Q9BWF2 | |
| KVLKKATLKVRDRVR | 91 | Q15349 | |
| ASAKPVERRKVIRKK | 61 | P20929 | |
| VERRKVIRKKVDPSK | 66 | P20929 |